StockData
Alignment Healthcare, Inc. logo

Alignment Healthcare, Inc. (ALHC) company profile

ALHCNasdaqHospital & Medical Service PlansFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/3053% above fair value
$6.72−0.90 (-11.81%)

Close on Nov 18, 2026Market cap $1.41BP/E 61.1Yield –

About Alignment Healthcare

Hospital & Medical Service Plans, SIC 6324

Alignment Healthcare, Inc. provides healthcare services and Medicare Advantage plans to senior citizens in the United States. The company operates through a single segment, partnering directly with the Centers for Medicare and Medicaid Services to coordinate and manage member healthcare. Its primary offerings consist of Medicare Advantage health maintenance organization and preferred provider organization plans. These plans cover inpatient and outpatient care, physician services, prescription drug benefits, and supplemental options such as dental and vision care. The company delivers proactive clinical care, manages chronic health conditions, and assists members in their communities, in their homes, and online. Its customer base consists of Medicare-eligible seniors who enroll in its private health plans.

The company is headquartered in Orange, California. As of December 31, 2025, Alignment Healthcare serves approximately 236,300 members. For the 2025 plan year, the organization provides coverage across 45 markets in five states, including 22 markets in California, 16 in North Carolina, three in Arizona, two in Nevada, and two in Texas.

Summary of the business section of Alignment Healthcare's latest annual report, written by StockData.

Company profile

Company

Legal name
Alignment Healthcare, Inc.
Founded
2013
Headquarters
Orange, CA
Address
1100 W. Town And Country Road, Suite 1600 92868
Phone
(844) 310-2247
Employees
1,849, Dec 31, 2025
Industry
Hospital & Medical Service Plans
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
Deloitte & Touche LLP, Costa Mesa, California

Stock & identifiers

Ticker
ALHC
Exchange
Nasdaq
IPO date
Mar 29, 2021
Shares outstanding
209M, Oct 26, 2026
Public float
$2.06B, Jun 30, 2025
Filer category
Large accelerated filer
SEC CIK
1832466
CUSIP
01625V104
ISIN
US01625V1044
FIGI
BBG00ZJ0DSR6
Share class FIGI
BBG00ZJ0DSS5
EIN
46-5596242

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Joseph S. KonowieckiEVP, Corporate Affairs, Director1,075,375
John E. KaoChief Executive Officer, Director1,814,239
Hyong KimChief Medical Officer299,271
Dawn Christine MaroneyPresident794,606
Shane J. HochradelChief Operations Officer87,719
Mark D. KentPresident - MSO102,567
James M. HeadChief Financial Officer173,495
Christopher J. JoyceChief Legal and Admin. Officer305,451
Sebastian BurzacchiCOO - Mgmt Services Org258,630
Robert L. ScavoChief Information Officer487,685
Andreas P. WagnerChief Human Resources Officer148,628
Adnan R. MansourChief Digital Officer48,456
Hakan KardesChief Experience Officer678,987
Robert Thomas FreemanChief Financial Officer1,557,348
Mark B. McClellanDirector370,531
Yon JordenDirector105,830
Nicholas Robbert VorhoffDirector173,408
Jacqueline B. KosecoffDirector303,963
Margaret M. McCarthyDirector144,441
Jody L. BilneyDirector129,267
David C. HodgsonDirector173,408

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025$11.28M$52.29M$3.57M$114$101
FY2024$6.37M$25.24M$2.72M$65$82
FY2023$14.30M-$2.67M$4.76M$50$83
FY2022$34.07M$25.81M$7.33M$68$78
FY2021$46.00M$37.30M$10.89M$81$98

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryStock awardsIncentive payOtherTotalvs. prior year
John Kao
Chief Executive Officer
$833.65K$8.50M$1.94M$420$11.28M+77%
Dawn Maroney
President
$676.92K$3.70M$1.05M$14.42K$5.44M+77%
James M. Head
Chief Financial Officer
$394.62K$2.50M$429.30K$1.91K$3.33M–
Thomas Freeman
Former Chief Financial Officer
$501.92K$1.90M$476.67K$8.22K$2.89M+1%
Hyong (Ken) Kim, M.D.
Chief Medical Officer
$560.00K$1.80M$754.59K$14.42K$3.13M+26%
Christopher Joyce
Chief Legal & Administrative Officer
$525.00K$1.75M$760.44K$14.00K$3.05M–

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

IPO

From the final prospectus (Form 424B4) and the first day of trading

Offering

Type
Initial public offering
Final prospectus filed
Mar 29, 2021
Offer price
$18.00
Securities offered
27,200,000
Gross proceeds
$489.60M
Exchange
Nasdaq
Lock-up ends (est.)
Sep 25, 2021

“The initial public offering price is $18.00 per share.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Employees

Headcount reported in annual reports

“As of December 31, 2025, we had 1,849 full-time employees in addition to seasonal employees who assist with the Medicare AEP.”

Corporate history

Events identified from SEC filings

See a number that looks wrong?